- Home
- PACB vs NAN Comparison
PACB vs NAN Comparison
Compare PACB & NAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACB
- NAN
- Stock Information
- Founded
- PACB 2000
- NAN 1999
- Country
- PACB United States
- NAN United States
- Employees
- PACB N/A
- NAN N/A
- Industry
- PACB Biotechnology: Laboratory Analytical Instruments
- NAN Investment Managers
- Sector
- PACB Industrials
- NAN Finance
- Exchange
- PACB Nasdaq
- NAN Nasdaq
- Market Cap
- PACB 364.2M
- NAN 352.5M
- IPO Year
- PACB 2010
- NAN N/A
- Fundamental
- Price
- PACB $1.19
- NAN $11.40
- Analyst Decision
- PACB Buy
- NAN
- Analyst Count
- PACB 13
- NAN 0
- Target Price
- PACB $2.46
- NAN N/A
- AVG Volume (30 Days)
- PACB 8.3M
- NAN 74.6K
- Earning Date
- PACB 05-08-2025
- NAN 01-01-0001
- Dividend Yield
- PACB N/A
- NAN 4.37%
- EPS Growth
- PACB N/A
- NAN N/A
- EPS
- PACB N/A
- NAN N/A
- Revenue
- PACB $154,014,000.00
- NAN N/A
- Revenue This Year
- PACB $7.15
- NAN N/A
- Revenue Next Year
- PACB $26.20
- NAN N/A
- P/E Ratio
- PACB N/A
- NAN N/A
- Revenue Growth
- PACB N/A
- NAN N/A
- 52 Week Low
- PACB $1.08
- NAN $9.11
- 52 Week High
- PACB $3.70
- NAN $11.34
- Technical
- Relative Strength Index (RSI)
- PACB 42.81
- NAN 53.73
- Support Level
- PACB $1.08
- NAN $11.40
- Resistance Level
- PACB $1.28
- NAN $11.53
- Average True Range (ATR)
- PACB 0.09
- NAN 0.10
- MACD
- PACB 0.01
- NAN 0.02
- Stochastic Oscillator
- PACB 39.66
- NAN 75.59
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
About NAN Nuveen New York Quality Municipal Income Fund
Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.